Type d'article
Etat
Reliure
Particularités
Livraison gratuite
Pays
Evaluation du vendeur
Edité par Fondationj Nationale De Transfusion Sanguine, Les Uli, 1990
Vendeur : Walk A Crooked Mile Books, Williamsburg, PA, Etats-Unis
Soft cover. Etat : Fine. Etat de la jaquette : No Dust Jacket. SCI 018237 LIVEZEY Good as new soft cover, in English.
Edité par Mdpi AG, 2023
ISBN 10 : 303659566XISBN 13 : 9783036595665
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
Livre
Etat : New.
Edité par MDPI AG, 2023
ISBN 10 : 303659566XISBN 13 : 9783036595665
Vendeur : PBShop.store US, Wood Dale, IL, Etats-Unis
Livre impression à la demande
HRD. Etat : New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Edité par Mdpi AG 11/29/2023, 2023
ISBN 10 : 303659566XISBN 13 : 9783036595665
Vendeur : BargainBookStores, Grand Rapids, MI, Etats-Unis
Livre
Hardback or Cased Book. Etat : New. Cell Therapy, Bispecific Antibodies and other Immunotherapies Against Cancer 1.37. Book.
Edité par Mdpi AG, 2023
ISBN 10 : 303659566XISBN 13 : 9783036595665
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
Livre
Etat : As New. Unread book in perfect condition.
Edité par Mdpi AG, 2023
ISBN 10 : 303659566XISBN 13 : 9783036595665
Vendeur : California Books, Miami, FL, Etats-Unis
Livre
Etat : New.
Edité par MDPI AG, 2023
ISBN 10 : 303659566XISBN 13 : 9783036595665
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
Livre impression à la demande
Etat : New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book.
Edité par Mdpi AG, 2023
ISBN 10 : 303659566XISBN 13 : 9783036595665
Vendeur : GreatBookPricesUK, Castle Donington, DERBY, Royaume-Uni
Livre
Etat : New.
Edité par LAP LAMBERT Academic Publishing Dez 2017, 2017
ISBN 10 : 6202198184ISBN 13 : 9786202198189
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Livre impression à la demande
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Immunotherapy as a therapeutic option for cancer therapy has contributed immensely to the success gained so far in the fight against cancer. Notwithstanding, the use of immunotherapy is not a common practice in most health facilities that handle cancer cases, and can be attributed to the fact that these immunotherapeutic agents are usually expensive compared to alternative options. This book therefore discusses the possible formats used in developing immunotherapeutic agents. Introduction and the first three chapters introduce the reader to the general concept of cancer and the various forms of cancer. The common therapeutic options and their respective therapeutic agents are also covered under these chapters. This is necessary to equip novices with basic knowledge about cancer and bring them to an appreciable level of understanding with respect to the concept of immunotherapy. Chapter four explains the various formats for developing immunotherapeutic agents as well as applications of these agents. This book will diffuse the perception that developing immunotherapeutic agent is a herculean task if not impossible, and also whip up your interest immunotherapy. 184 pp. Englisch.
Edité par Mdpi AG, 2023
ISBN 10 : 303659566XISBN 13 : 9783036595665
Vendeur : GreatBookPricesUK, Castle Donington, DERBY, Royaume-Uni
Livre
Etat : As New. Unread book in perfect condition.
Edité par MDPI AG, 2023
ISBN 10 : 303659566XISBN 13 : 9783036595665
Vendeur : PBShop.store UK, Fairford, GLOS, Royaume-Uni
Livre impression à la demande
HRD. Etat : New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Edité par Mdpi AG, 2023
ISBN 10 : 303659566XISBN 13 : 9783036595665
Vendeur : GF Books, Inc., Hawthorne, CA, Etats-Unis
Livre
Etat : New. Book is in NEW condition. 1.37.
Edité par Mdpi AG, 2023
ISBN 10 : 303659566XISBN 13 : 9783036595665
Vendeur : Books Unplugged, Amherst, NY, Etats-Unis
Livre
Etat : Good. Buy with confidence! Book is in good condition with minor wear to the pages, binding, and minor marks within 1.37.
Edité par LAP LAMBERT Academic Publishing, 2017
ISBN 10 : 6202198184ISBN 13 : 9786202198189
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Livre impression à la demande
Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Immunotherapy as a therapeutic option for cancer therapy has contributed immensely to the success gained so far in the fight against cancer. Notwithstanding, the use of immunotherapy is not a common practice in most health facilities that handle cancer cases, and can be attributed to the fact that these immunotherapeutic agents are usually expensive compared to alternative options. This book therefore discusses the possible formats used in developing immunotherapeutic agents. Introduction and the first three chapters introduce the reader to the general concept of cancer and the various forms of cancer. The common therapeutic options and their respective therapeutic agents are also covered under these chapters. This is necessary to equip novices with basic knowledge about cancer and bring them to an appreciable level of understanding with respect to the concept of immunotherapy. Chapter four explains the various formats for developing immunotherapeutic agents as well as applications of these agents. This book will diffuse the perception that developing immunotherapeutic agent is a herculean task if not impossible, and also whip up your interest immunotherapy.
Edité par LAP LAMBERT Academic Publishing, 2017
ISBN 10 : 6202198184ISBN 13 : 9786202198189
Vendeur : moluna, Greven, Allemagne
Livre impression à la demande
Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Omane Acheampong DesmondDr. Desmond Omane Acheampong is a Senior Lecturer and Head of the Department of Biomedical Sciences, University of Cape Coast. He holds a PhD in Microbiological and Biochemical Pharmacy and MSc in Clinical Mic.
Edité par Springer, 2014
ISBN 10 : 3642432077ISBN 13 : 9783642432071
Vendeur : booksXpress, Bayonne, NJ, Etats-Unis
Livre
Soft Cover. Etat : new.
Edité par Springer, 2011
ISBN 10 : 3642209092ISBN 13 : 9783642209093
Vendeur : booksXpress, Bayonne, NJ, Etats-Unis
Livre
Hardcover. Etat : new.
Edité par Springer Berlin Heidelberg Dez 2014, 2014
ISBN 10 : 3642432077ISBN 13 : 9783642432071
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Livre impression à la demande
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The concept of using bispecific antibodies for cancer therapy by retargeting immune effector cells was developed several years ago. Initial clinical studies were rather disappointing mainly due to low efficacy, severe side effects and the immunogenicity of the bispecific antibodies. The progress in antibody engineering finally led to the generation of new classes of bispecific antibodies lacking these obstacles. In addition, new applications were established, such as pre-targeting strategies in radioimmunotherapy and dual targeting approaches in order to improve binding, selectivity and efficacy.In this book, the different ways of generating bispecific antibodies are described, with emphasis on recombinant formats. The various applications of bispecific antibodies, e.g. in cellular cancer immunotherapy, radioimmunotherapy and pretargeting strategies are covered, and emerging applications such as dual targeting strategies, which involve the simultaneous inhibition of two targets, are addressed. 392 pp. Englisch.
Edité par Springer, 2014
ISBN 10 : 3642432077ISBN 13 : 9783642432071
Vendeur : Lucky's Textbooks, Dallas, TX, Etats-Unis
Livre
Etat : New.
Edité par Springer, 2011
ISBN 10 : 3642209092ISBN 13 : 9783642209093
Vendeur : Lucky's Textbooks, Dallas, TX, Etats-Unis
Livre
Etat : New.
Edité par Springer, 2011
ISBN 10 : 3642209092ISBN 13 : 9783642209093
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
Livre
Etat : New.
Edité par Springer Berlin Heidelberg, 2011
ISBN 10 : 3642209092ISBN 13 : 9783642209093
Vendeur : moluna, Greven, Allemagne
Livre impression à la demande
Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Presents the recent advances in antibody engineering and in the various clinical applicationsAn invaluable resource for both experts and those new to the fieldWith contributions by international experts from research and biotech companies.
Edité par Springer Berlin Heidelberg, 2014
ISBN 10 : 3642432077ISBN 13 : 9783642432071
Vendeur : moluna, Greven, Allemagne
Livre impression à la demande
Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Presents the recent advances in antibody engineering and in the various clinical applicationsAn invaluable resource for both experts and those new to the fieldWith contributions by international experts from research and biotech companies.
Edité par Springer, 2014
ISBN 10 : 3642432077ISBN 13 : 9783642432071
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
Livre impression à la demande
Etat : New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book.
Edité par Springer, 2011
ISBN 10 : 3642209092ISBN 13 : 9783642209093
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
Livre impression à la demande
Etat : New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book.
Edité par Springer Berlin Heidelberg Jul 2011, 2011
ISBN 10 : 3642209092ISBN 13 : 9783642209093
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Livre
Buch. Etat : Neu. Neuware -The concept of using bispecific antibodies for cancer therapy by retargeting immune effector cells was developed several years ago. Initial clinical studies were rather disappointing mainly due to low efficacy, severe side effects and the immunogenicity of the bispecific antibodies. The progress in antibody engineering finally led to the generation of new classes of bispecific antibodies lacking these obstacles. In addition, new applications were established, such as pre-targeting strategies in radioimmunotherapy and dual targeting approaches in order to improve binding, selectivity and efficacy.In this book, the different ways of generating bispecific antibodies are described, with emphasis on recombinant formats. The various applications of bispecific antibodies, e.g. in cellular cancer immunotherapy, radioimmunotherapy and pretargeting strategies are covered, and emerging applications such as dual targeting strategies, which involve the simultaneous inhibition of two targets, are addressed. 392 pp. Englisch.
Edité par Springer, 2011
ISBN 10 : 3642209092ISBN 13 : 9783642209093
Vendeur : GreatBookPricesUK, Castle Donington, DERBY, Royaume-Uni
Livre
Etat : New.
Edité par Springer Berlin Heidelberg, 2011
ISBN 10 : 3642209092ISBN 13 : 9783642209093
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Livre
Buch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - The concept of using bispecific antibodies for cancer therapy by retargeting immune effector cells was developed several years ago. Initial clinical studies were rather disappointing mainly due to low efficacy, severe side effects and the immunogenicity of the bispecific antibodies. The progress in antibody engineering finally led to the generation of new classes of bispecific antibodies lacking these obstacles. In addition, new applications were established, such as pre-targeting strategies in radioimmunotherapy and dual targeting approaches in order to improve binding, selectivity and efficacy.In this book, the different ways of generating bispecific antibodies are described, with emphasis on recombinant formats. The various applications of bispecific antibodies, e.g. in cellular cancer immunotherapy, radioimmunotherapy and pretargeting strategies are covered, and emerging applications such as dual targeting strategies, which involve the simultaneous inhibition of two targets, are addressed.
Edité par Springer Berlin Heidelberg, 2014
ISBN 10 : 3642432077ISBN 13 : 9783642432071
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Livre
Taschenbuch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - The concept of using bispecific antibodies for cancer therapy by retargeting immune effector cells was developed several years ago. Initial clinical studies were rather disappointing mainly due to low efficacy, severe side effects and the immunogenicity of the bispecific antibodies. The progress in antibody engineering finally led to the generation of new classes of bispecific antibodies lacking these obstacles. In addition, new applications were established, such as pre-targeting strategies in radioimmunotherapy and dual targeting approaches in order to improve binding, selectivity and efficacy.In this book, the different ways of generating bispecific antibodies are described, with emphasis on recombinant formats. The various applications of bispecific antibodies, e.g. in cellular cancer immunotherapy, radioimmunotherapy and pretargeting strategies are covered, and emerging applications such as dual targeting strategies, which involve the simultaneous inhibition of two targets, are addressed.
Edité par Springer, 2011
ISBN 10 : 3642209092ISBN 13 : 9783642209093
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
Livre
Etat : As New. Unread book in perfect condition.